Atrial natriuretic peptide infusion in primary aldosteronism: renal, hemodynamic and hormonal effects

Stefano Rocco, Giuseppe Opocher, Guido Carpenè

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We have previously shown that a bolus injection of α-human atrial natriuretic peptide (α-h-ANP) (100 µg) in patients with primary aldosteronism induces a transient decrease of blood pressure and a marked natriuresis, but no changes in plasma al-dosterone levels. Eight additional cases were studied with a different protocol. α-h-ANP was infused at the dose of 50 ng/kg/min over 1 h, after a bolus of 50 µg; saline alone was infused as control. Blood pressure, heart rate, plasma aldosterone, plasma renin activity, cortisol, serum and urinary Na and K and urinary volume were measured. A slight fall in blood pressure, without heart rate changes, was obtained within the first 5 min; this lasted throughout the infusion and for 1 h afterwards. Urinary volume and urinary sodium were significantly higher than controls during the first 2 h, while urinary potassium slightly increased only during the first hour. Plasma renin activity remained suppressed. Plasma aldosterone levels were similar throughout the infusion. Cortisol was not significantly different than placebo except that there was a significant rise after stopping ANP. These data confirm the potent natriuretic effect of ANP infusion and the lack of correlation between ANP induced natriuresis and the effect of ANP on aldosterone in patients with primary aldosteronism.

Original languageEnglish
Pages (from-to)668-673
Number of pages6
JournalAmerican Journal of Hypertension
Volume3
Issue number9
DOIs
Publication statusPublished - 1990

Fingerprint

Hyperaldosteronism
Atrial Natriuretic Factor
Hemodynamics
Kidney
Aldosterone
Natriuresis
Blood Pressure
Renin
Hydrocortisone
Heart Rate
Natriuretic Agents
Potassium
Sodium
Placebos
Injections
Serum

Keywords

  • Atrial natriuretic
  • Peptide aldosteron
  • Primary aldosteronism

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Atrial natriuretic peptide infusion in primary aldosteronism : renal, hemodynamic and hormonal effects. / Rocco, Stefano; Opocher, Giuseppe; Carpenè, Guido.

In: American Journal of Hypertension, Vol. 3, No. 9, 1990, p. 668-673.

Research output: Contribution to journalArticle

@article{00db1d4d41604781a6c32891504a62fc,
title = "Atrial natriuretic peptide infusion in primary aldosteronism: renal, hemodynamic and hormonal effects",
abstract = "We have previously shown that a bolus injection of α-human atrial natriuretic peptide (α-h-ANP) (100 µg) in patients with primary aldosteronism induces a transient decrease of blood pressure and a marked natriuresis, but no changes in plasma al-dosterone levels. Eight additional cases were studied with a different protocol. α-h-ANP was infused at the dose of 50 ng/kg/min over 1 h, after a bolus of 50 µg; saline alone was infused as control. Blood pressure, heart rate, plasma aldosterone, plasma renin activity, cortisol, serum and urinary Na and K and urinary volume were measured. A slight fall in blood pressure, without heart rate changes, was obtained within the first 5 min; this lasted throughout the infusion and for 1 h afterwards. Urinary volume and urinary sodium were significantly higher than controls during the first 2 h, while urinary potassium slightly increased only during the first hour. Plasma renin activity remained suppressed. Plasma aldosterone levels were similar throughout the infusion. Cortisol was not significantly different than placebo except that there was a significant rise after stopping ANP. These data confirm the potent natriuretic effect of ANP infusion and the lack of correlation between ANP induced natriuresis and the effect of ANP on aldosterone in patients with primary aldosteronism.",
keywords = "Atrial natriuretic, Peptide aldosteron, Primary aldosteronism",
author = "Stefano Rocco and Giuseppe Opocher and Guido Carpen{\`e}",
year = "1990",
doi = "10.1093/ajh/3.9.668",
language = "English",
volume = "3",
pages = "668--673",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Atrial natriuretic peptide infusion in primary aldosteronism

T2 - renal, hemodynamic and hormonal effects

AU - Rocco, Stefano

AU - Opocher, Giuseppe

AU - Carpenè, Guido

PY - 1990

Y1 - 1990

N2 - We have previously shown that a bolus injection of α-human atrial natriuretic peptide (α-h-ANP) (100 µg) in patients with primary aldosteronism induces a transient decrease of blood pressure and a marked natriuresis, but no changes in plasma al-dosterone levels. Eight additional cases were studied with a different protocol. α-h-ANP was infused at the dose of 50 ng/kg/min over 1 h, after a bolus of 50 µg; saline alone was infused as control. Blood pressure, heart rate, plasma aldosterone, plasma renin activity, cortisol, serum and urinary Na and K and urinary volume were measured. A slight fall in blood pressure, without heart rate changes, was obtained within the first 5 min; this lasted throughout the infusion and for 1 h afterwards. Urinary volume and urinary sodium were significantly higher than controls during the first 2 h, while urinary potassium slightly increased only during the first hour. Plasma renin activity remained suppressed. Plasma aldosterone levels were similar throughout the infusion. Cortisol was not significantly different than placebo except that there was a significant rise after stopping ANP. These data confirm the potent natriuretic effect of ANP infusion and the lack of correlation between ANP induced natriuresis and the effect of ANP on aldosterone in patients with primary aldosteronism.

AB - We have previously shown that a bolus injection of α-human atrial natriuretic peptide (α-h-ANP) (100 µg) in patients with primary aldosteronism induces a transient decrease of blood pressure and a marked natriuresis, but no changes in plasma al-dosterone levels. Eight additional cases were studied with a different protocol. α-h-ANP was infused at the dose of 50 ng/kg/min over 1 h, after a bolus of 50 µg; saline alone was infused as control. Blood pressure, heart rate, plasma aldosterone, plasma renin activity, cortisol, serum and urinary Na and K and urinary volume were measured. A slight fall in blood pressure, without heart rate changes, was obtained within the first 5 min; this lasted throughout the infusion and for 1 h afterwards. Urinary volume and urinary sodium were significantly higher than controls during the first 2 h, while urinary potassium slightly increased only during the first hour. Plasma renin activity remained suppressed. Plasma aldosterone levels were similar throughout the infusion. Cortisol was not significantly different than placebo except that there was a significant rise after stopping ANP. These data confirm the potent natriuretic effect of ANP infusion and the lack of correlation between ANP induced natriuresis and the effect of ANP on aldosterone in patients with primary aldosteronism.

KW - Atrial natriuretic

KW - Peptide aldosteron

KW - Primary aldosteronism

UR - http://www.scopus.com/inward/record.url?scp=0025129571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025129571&partnerID=8YFLogxK

U2 - 10.1093/ajh/3.9.668

DO - 10.1093/ajh/3.9.668

M3 - Article

C2 - 2145872

AN - SCOPUS:0025129571

VL - 3

SP - 668

EP - 673

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 9

ER -